Advanced search
Publication Cover
OncoImmunology Volume 6, 2017 - Issue 5
Submit an article Journal homepage
1,939
Views
16
CrossRef citations to date
0
Altmetric
Review

Cellular immunotherapies for cancer

Pedro BerraondoProgram of Immunology and Immunotherapy, Center for Applied Medical Research (CIMA), Pamplona, Spain;Navarra Institute for Health Research (IDISNA), Pamplona, Spain;Centro de Investigación Biomédica en Red de Cáncer (CIBERONC), SpainORCID Iconhttp://orcid.org/0000-0001-7410-1865
ORCID Icon,
Sara LabianoProgram of Immunology and Immunotherapy, Center for Applied Medical Research (CIMA), Pamplona, Spain;Navarra Institute for Health Research (IDISNA), Pamplona, Spain
,
Luna MinuteProgram of Immunology and Immunotherapy, Center for Applied Medical Research (CIMA), Pamplona, Spain;Navarra Institute for Health Research (IDISNA), Pamplona, Spain
,
Iñaki EtxeberriaProgram of Immunology and Immunotherapy, Center for Applied Medical Research (CIMA), Pamplona, Spain;Navarra Institute for Health Research (IDISNA), Pamplona, Spain
,
Marcos VasquezProgram of Immunology and Immunotherapy, Center for Applied Medical Research (CIMA), Pamplona, Spain;Navarra Institute for Health Research (IDISNA), Pamplona, Spain
,
Alvaro Sanchez-ArraezProgram of Immunology and Immunotherapy, Center for Applied Medical Research (CIMA), Pamplona, Spain;Navarra Institute for Health Research (IDISNA), Pamplona, Spain
,
Alvaro TeijeiraProgram of Immunology and Immunotherapy, Center for Applied Medical Research (CIMA), Pamplona, Spain;Navarra Institute for Health Research (IDISNA), Pamplona, Spain;Centro de Investigación Biomédica en Red de Cáncer (CIBERONC), Spain
&
Ignacio MeleroProgram of Immunology and Immunotherapy, Center for Applied Medical Research (CIMA), Pamplona, Spain;Navarra Institute for Health Research (IDISNA), Pamplona, Spain;Centro de Investigación Biomédica en Red de Cáncer (CIBERONC), Spain;Servicio de Inmunología e Inmunoterapia, Clínica Universidad de Navarra, Pamplona, SpainCorrespondence[email protected]
ORCID Iconhttp://orcid.org/0000-0002-1360-348X
ORCID Icon show all
Article: e1306619 | Received 08 Mar 2017, Accepted 09 Mar 2017, Published online: 02 May 2017

Citations (16)

Keep up to date with the latest research on this topic with citation updates for this article.

Subscribe to citation updates

Read on this site (4)

Jenny Sprooten, Jolien Ceusters, An Coosemans, Patrizia Agostinis, Steven De Vleeschouwer, Laurence Zitvogel, Guido Kroemer, Lorenzo Galluzzi & Abhishek D. Garg. (2019) Trial watch: dendritic cell vaccination for cancer immunotherapy. OncoImmunology 8:11.
Read now
Lucillia Bezu, Oliver Kepp, Giulia Cerrato, Jonathan Pol, Jitka Fucikova, Radek Spisek, Laurence Zitvogel, Guido Kroemer & Lorenzo Galluzzi. (2018) Trial watch: Peptide-based vaccines in anticancer therapy. OncoImmunology 7:12.
Read now
Jonathan G. Pol, Sarah Lévesque, Samuel T. Workenhe, Shashi Gujar, Fabrice Le Boeuf, Derek R. Clements, Jean-Eudes Fahrner, Laetitia Fend, John C. Bell, Karen L. Mossman, Jitka Fucikova, Radek Spisek, Laurence Zitvogel, Guido Kroemer & Lorenzo Galluzzi. (2018) Trial Watch: Oncolytic viro-immunotherapy of hematologic and solid tumors. OncoImmunology 7:12.
Read now
O. Adotevi, Y. Godet, J. Galaine, Z. Lakkis, I. Idirene, J. M. Certoux, M. Jary, R. Loyon, C. Laheurte, S. Kim, A. Dormoy, F. Pouthier, C. Barisien, F. Fein, P. Tiberghien, X. Pivot, S. Valmary-Degano, C. Ferrand, P. Morel, E. Delabrousse & C. Borg. (2018) In situ delivery of allogeneic natural killer cell (NK) combined with Cetuximab in liver metastases of gastrointestinal carcinoma: A phase I clinical trial. OncoImmunology 7:5.
Read now

Articles from other publishers (12)

Jian Xiong, Junyan Chen, Xiang Sun, Rui Zhao & Kefei Gao. (2023) Prognostic role of long non-coding RNA USP30-AS1 in ovarian cancer: insights into immune cell infiltration in the tumor microenvironment. Aging.
Crossref
Meng Jin, Yingying Zhao, Zong-Jie Guan & Yu Fang. (2023) Porous Framework Materials for Bioimaging and Cancer Therapy. Molecules 28:3, pages 1360.
Crossref
Hui Jiang, Bo Ling Chu, Jiao He, Zhi Liu & Ling Yang. (2022) Expression and prognosis analyses of the fibronectin type-III domain-containing (FNDC) protein family in human cancers: A Review. Medicine 101:49, pages e31854.
Crossref
Gisela Weiz, Maria I. Molejon, Mariana Malvicini, Caecilia H. C. Sukowati, Claudio Tiribelli, Guillermo Mazzolini & Javier D. Breccia. (2021) Glycosylated 4‐methylumbelliferone as a targeted therapy for hepatocellular carcinoma. Liver International 42:2, pages 444-457.
Crossref
Mogammad Baaghith Hamid, Antonio Mendes Serafin & John Mbabuni Akudugu. (2021) Selective therapeutic benefit of X-rays and inhibitors of EGFR, PI3K/mTOR, and Bcl-2 in breast, lung, and cervical cancer cells. European Journal of Pharmacology 912, pages 174612.
Crossref
Xinyuan Zhang, Chelsea F. Mariano, Yuta Ando & Keyue Shen. (2020) Bioengineering tools for probing intracellular events in T lymphocytes. WIREs Mechanisms of Disease 13:4.
Crossref
Katarzyna Nazimek & Krzysztof Bryniarski. (2020) Approaches to inducing antigen‐specific immune tolerance in allergy and autoimmunity: Focus on antigen‐presenting cells and extracellular vesicles. Scandinavian Journal of Immunology 91:6.
Crossref
Alessandra Iscaro, Nutter F. Howard & Munitta Muthana. (2019) Nanoparticles: Properties and Applications in Cancer Immunotherapy. Current Pharmaceutical Design 25:17, pages 1962-1979.
Crossref
Marcelo M. Rodríguez, Esteban Fiore, Juan Bayo, Catalina Atorrasagasti, Mariana García, Agostina Onorato, Luciana Domínguez, Mariana Malvicini & Guillermo Mazzolini. (2018) 4Mu Decreases CD47 Expression on Hepatic Cancer Stem Cells and Primes a Potent Antitumor T Cell Response Induced by Interleukin-12. Molecular Therapy 26:12, pages 2738-2750.
Crossref
Israt S. Alam, Aaron T. Mayer, Idit Sagiv-Barfi, Kezheng Wang, Ophir Vermesh, Debra K. Czerwinski, Emily M. Johnson, Michelle L. James, Ronald Levy & Sanjiv S. Gambhir. (2018) Imaging activated T cells predicts response to cancer vaccines. Journal of Clinical Investigation 128:6, pages 2569-2580.
Crossref
He Li, Yao Huang, Du-Qing Jiang, Lian-Zhen Cui, Zhou He, Chao Wang, Zhi-Wei Zhang, Hai-Li Zhu, Yong-Mei Ding, Lin-Fang Li, Qiang Li, Hua-Jun Jin & Qi-Jun Qian. (2018) Antitumor activity of EGFR-specific CAR T cells against non-small-cell lung cancer cells in vitro and in mice. Cell Death & Disease 9:2.
Crossref
Shuang Li, Jing Wu, Shan Zhu, Yong-Jun Liu & Jingtao Chen. (2017) Disease-Associated Plasmacytoid Dendritic Cells. Frontiers in Immunology 8.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.